GlassScriptPhysician profile
Lauren E Gebauer
NPI 1386960961
$1,863.26
in general payments reported to CMS, 2019-2025
18 companies · $679 in 2025
The $679 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2021: $12.94 · 2022: $52.38 · 2023: $133 · 2024: $512 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $494.71 | 2019-2025 | Skyrizi |
| Regeneron Healthcare Solutions, INC. | $217.15 | 2024-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $210.51 | 2019-2025 | |
| Lilly USA, LLC | $164.59 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $150.89 | 2022-2025 | Tremfya |
| Ucb, INC. | $111.07 | 2019-2025 | Bimzelx |
| Genzyme Corporation | $95.43 | 2019-2024 | |
| Incyte Corporation | $95.33 | 2025 | Opzelura |
| Leo Pharma INC. | $65.52 | 2024-2025 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $61.59 | 2023-2024 | Sotyktu |
| Pfizer INC. | $45.55 | 2019-2025 | |
| Amgen INC. | $28.57 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $23.32 | 2024 | Duobrii |
| Dermira, INC. | $22.70 | 2019 | |
| Botanix Sb INC | $21.41 | 2025 | Sofdra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $18.58 | 2019 | |
| Smith+Nephew, INC. | $18.40 | 2023 | Grafix Pl, Grafix |
| Sun Pharmaceutical Industries INC. | $17.94 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Gebauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.